Avalere Health

HR Technology Conference & Exposition® Europe Announces Additional Agenda Details

Retrieved on: 
Monday, March 18, 2024
UX, HR, Organization, Conference, Noise, Corporate sustainability, Digital, Expert, Business, General partnership, PALM, Research, Transformation, Organizational culture, Olympus Corporation, Senior, RAI Amsterdam, Avalere Health, Stanford University, ETC, Workplace, Tech, Management

WEST PALM BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- The upcoming HR Technology Conference & Exposition® Europe today shared additional agenda details in the lead-up to the two-day event taking place at the RAI Amsterdam, May 2 – 3, 2024.

Key Points: 
  • WEST PALM BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- The upcoming HR Technology Conference & Exposition® Europe today shared additional agenda details in the lead-up to the two-day event taking place at the RAI Amsterdam, May 2 – 3, 2024.
  • Beyond the previously announced keynote sessions , the HR Technology Conference Europe will feature a full slate of Tech Talks, Ask the Experts and much more.
  • Rebecca McKenna, Senior Vice President, HR Portfolio at ETC, shared, “The HR Technology Conference Europe promises to be an exceptional event that looks at the issues impacting today’s HR teams from multiple vantage points.
  • Attendees will have the opportunity to hear from industry analysts, practitioners and solution providers, all focused on advancing the HR discipline and improving the very nature of work.”
    The agenda for the HR Technology Conference & Exposition® Europe is updated on a regular basis.

RevHealth strengthens C-suite naming Marcia Goddard as Chief Creative Officer

Retrieved on: 
Wednesday, February 21, 2024
Guinness, Acquisition, Rev, Culture, Hope, Creativity, Avalere Health, Depression

MORRISTOWN, N.J., Feb. 21, 2024 /PRNewswire/ -- RevHealth, a full-service independent pharmaceutical marketing and communications agency, today named Marcia Goddard as Chief Creative Officer.

Key Points: 
  • MORRISTOWN, N.J., Feb. 21, 2024 /PRNewswire/ -- RevHealth, a full-service independent pharmaceutical marketing and communications agency, today named Marcia Goddard as Chief Creative Officer.
  • Goddard was most recently Chief Creative Officer at Fishawack Health, which she helped to rebrand as Avalere Health.
  • Goddard brings deep expertise in collaborative team building, having led McCann Health NJ as President and before that as Chief Creative Officer.
  • "My core strength is problem solving— pushing capabilities to address evolving client and industry needs," said Goddard.

Lauren Barnes Joins Ossium Health’s Board of Directors

Retrieved on: 
Monday, February 12, 2024
Oncology, Health, Infectious Diseases, Stem Cells, Pharmaceutical, Biotechnology, Bone marrow, Senior, Commercialization, Amgen, Growth, Drug design, Access, Safety, Vertex Pharmaceuticals, Patient, Lauren Barnes, Avalere Health, Cancer Support Community

Ossium Health, an innovative bioengineering company that established a first-of-its-kind bone marrow banking platform, today announced the appointment of Lauren Barnes to its Board of Directors.

Key Points: 
  • Ossium Health, an innovative bioengineering company that established a first-of-its-kind bone marrow banking platform, today announced the appointment of Lauren Barnes to its Board of Directors.
  • “Lauren’s expertise and proven track record in biopharmaceutical commercialization are invaluable assets,” said Kevin Caldwell, Ossium’s CEO, Co-Founder & President.
  • In addition, Barnes serves as a board member for Ascelia Pharma AB, a Swedish oncology drug development company with two late-stage drug candidates, and she recently completed her time as Chair of the Board of Directors for the non-profit Cancer Support Community.
  • “I am incredibly excited to join Ossium’s Board of Directors at this pivotal moment in the company’s journey,” said Barnes.

Avalere Health Appoints New President of Medical To Lead a Tech-Enabled Future of Medical Affairs

Retrieved on: 
Tuesday, February 6, 2024
Intelligence, Science, Congress, Avalere Health, Marketing, Health, Real Chemistry, Creativity, Advertising, Omnicom Group

LONDON, Feb. 6, 2024 /PRNewswire/ -- Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.

Key Points: 
  • LONDON, Feb. 6, 2024 /PRNewswire/ -- Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.
  • Baoutis will lead a team of 350+ scientific communicators into a future of medical communications fueled by an alchemy of science, creativity and technology.
  • Avalere Health has a deep heritage in this field, forming more than 20 years ago as a medical communications agency.
  • "I'm thrilled to join as the President of Medical at Avalere Health during a paradigm shift in medical communications," said Baoutis.

Avalere Health Appoints New President of Medical To Lead a Tech-Enabled Future of Medical Affairs

Retrieved on: 
Tuesday, February 6, 2024
Intelligence, Science, Congress, Avalere Health, Marketing, Health, Real Chemistry, Creativity, Advertising, Omnicom Group

LONDON, Feb. 6, 2024 /PRNewswire/ -- Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.

Key Points: 
  • LONDON, Feb. 6, 2024 /PRNewswire/ -- Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.
  • Baoutis will lead a team of 350+ scientific communicators into a future of medical communications fueled by an alchemy of science, creativity and technology.
  • Avalere Health has a deep heritage in this field, forming more than 20 years ago as a medical communications agency.
  • "I'm thrilled to join as the President of Medical at Avalere Health during a paradigm shift in medical communications," said Baoutis.

Havas Health & You Appoints Afshan Rizvi Hussain as Global Rare Disease Lead

Retrieved on: 
Thursday, January 25, 2024
Avalere Health, IgA nephropathy, HH, Knowledge, CHIEF, Mentorship, Disease, Immunoglobulin A, Health literacy, Growth, Management

NEW YORK, Jan. 25, 2024 /PRNewswire/ - Havas Health & You (HH&Y), the premier healthcare marketing and communications agency, announced today that Afshan Rizvi Hussain has been appointed Managing Director, Global Rare Disease Lead, for the network.

Key Points: 
  • NEW YORK, Jan. 25, 2024 /PRNewswire/ - Havas Health & You (HH&Y), the premier healthcare marketing and communications agency, announced today that Afshan Rizvi Hussain has been appointed Managing Director, Global Rare Disease Lead, for the network.
  • In this newly created role, Afshan will drive the Havas Health & You approach to deepen connections with rare disease communities and engage with our network clients to optimize rare disease commercialization efforts.
  • As a leader in the specialized rare disease sector, Havas affirms with this appointment their commitment to continued growth and innovation.
  • "Afshan has dedicated her career to developing a very robust understanding of rare disease communities and shining a light on underrepresented communities," said Daniel Rubin, Group President North America,  Havas Health & You.

Doceree concludes Season 1 of 'The Next Marketing With HJ' with a stellar finale featuring WPP's Chief Creative Officer, Rob Reilly

Retrieved on: 
Tuesday, January 9, 2024
Senior, Avalere Health, Digital health, Season 2, Harshit, HJ, Knowledge, Season, Stand Up and Scream, WPP, HCP, Anecdote, Series finale, Marketing, Season One, Tourism

PARSIPPANY, N.J. , Jan. 9, 2024 /PRNewswire/ -- Doceree, the leading global platform for HCP programmatic marketing, concluded 2023 on a new high as Harshit Jain MD, Founder & Global CEO, Doceree, exchanged revolutionary insights with Rob Reilly, Global Chief Creative Officer, WPP, about the paramount value of culturally inclusive marketing in today's digital age, in the final episode of the refreshing knowledge-first series, 'The Next Marketing with HJ'.

Key Points: 
  • Launched on Doceree's YouTube channel on 1st August 2023, Season 1 of the first-of-its-kind talk show hosted by Harshit Jain MD encourages dynamic knowledge-sharing with global marketing/advertising experts through eight enriching and entertaining episodes.
  • As the new-age marketers strive to build authentic relationships and connections, the entertaining series serves as a guide through the ever-changing landscape of healthcare marketing.
  • I am immensely grateful to all the experts who supported me in this endeavour and am all set to launch Season 2 soon."
  • Reflecting on his participation in the show, Rob Reilly, Chief Creative Officer at WPP, says, "As creatives, it's essential to be curious and to look for inspiration and knowledge in unexpected places.

BrightStar Care® Celebrates a Year of Franchise Expansion and Industry Accolades, Paving the Way for Success in 2024

Retrieved on: 
Wednesday, November 29, 2023
Woman, Patient, Avalere Health, BrightStar Care, Franchise Times, Dictionary, Entrepreneur (magazine), Entrepreneurship, Partnership, Growth, Health, Publication, Publishing, Nursing, Veteran

GURNEE, Ill., Nov. 29, 2023 /PRNewswire-PRWeb/ -- BrightStar Care, the nation's leading home care and medical staffing franchise with more than 380 corporate and franchise agencies, led the franchise innovation conversation throughout 2023. The year witnessed significant franchise growth, with seventeen franchise owners expanding their home care footprint. BrightStar Care also garnered prestigious accolades from top publications including Entrepreneur, Franchise Times, Franchise Dictionary Magazine, and Franchise Update Media. These accolades, coupled with BrightStar Care's franchise expansion, signify the enduring strength of the home care franchise. It remains an impressive and continually growing concept, appealing to both seasoned franchisees and enthusiastic newcomers, as well as entrepreneurs.

Key Points: 
  • BrightStar Care also garnered prestigious accolades from top publications including Entrepreneur, Franchise Times, Franchise Dictionary Magazine, and Franchise Update Media.
  • These accolades, coupled with BrightStar Care's franchise expansion, signify the enduring strength of the home care franchise.
  • In addition, BrightStar Care Founder and CEO Shelly Sun was recognized as one of Franchise Dictionary Magazine's 50 Women of Wonder .
  • In 2024, BrightStar Care anticipates additional franchise deals as the agency expands its renowned higher standard of care into new territories.

Advanced Medical Pricing Solutions Appoints Roy Beveridge, MD as Board Member

Retrieved on: 
Tuesday, November 7, 2023
Humana, Johns Hopkins University, Health, Johns Hopkins, Human, MD, Population health, BA, AMPS, Medical degree, McKesson Corporation, Biology, Internal medicine, University, Cornell University, Senior advisor, Patient, Avalere Health, Oncology, Nursing, Health care

PHOENIX, Nov. 7, 2023 /PRNewswire/ -- Advanced Medical Pricing Solutions ("AMPS"), a Cimarron Healthcare Capital portfolio company empowering self-insured employers and healthcare stakeholders in delivering affordable, fair, and transparent medical and prescription benefits, today announced the appointment of Dr. Roy Beveridge, MD to its Board.

Key Points: 
  • PHOENIX, Nov. 7, 2023 /PRNewswire/ -- Advanced Medical Pricing Solutions ("AMPS"), a Cimarron Healthcare Capital portfolio company empowering self-insured employers and healthcare stakeholders in delivering affordable, fair, and transparent medical and prescription benefits, today announced the appointment of Dr. Roy Beveridge, MD to its Board.
  • "We're excited to welcome Dr. Beveridge to the Board of AMPS," said James Nadauld, AMPS Board Chair and Managing Partner of Cimarron Healthcare Capital.
  • "The affordability and transparency of health benefits is a top issue for employers, healthcare stakeholders and patients," said Dr. Roy Beveridge, Board Member of AMPS.
  • "As we broaden our capabilities and target markets, Roy will be a trusted voice on our board and valued member of the AMPS team."

New Report Raises Key Questions About the Inflation Reduction Act Impact on Cardiovascular Drug Development

Retrieved on: 
Tuesday, October 31, 2023
Shift, FDA, Research, Cardiovascular Drugs and Therapy, Medicare, IRA, MD, Drug development, Death, Inflation Reduction Act of 2022, Avalere Health, Inflation, Centers for Medicare & Medicaid Services, Patient, Partnership, PACH, Cardiovascular disease, Medical device, Pharmaceutical industry, Dietary supplement

WASHINGTON, Oct. 31, 2023 /PRNewswire/ -- A new paper by Avalere Health indicates that lifecycle pressures put in place by the Inflation Reduction Act could uniquely impact cardiovascular drug development. These pressures may create outsized disincentives for therapies that treat America's #1 killer.

Key Points: 
  • WASHINGTON, Oct. 31, 2023 /PRNewswire/ -- A new paper by Avalere Health indicates that lifecycle pressures put in place by the Inflation Reduction Act could uniquely impact cardiovascular drug development.
  • For cardiovascular patients, price negotiations could uniquely impact cardiovascular drug development and the types of treatments available to patients, Avalere's paper indicates.
  • By comparing the development process for cardiovascular drugs to other chronic disease states, the paper highlights unique aspects of cardiovascular drug development, which in turn emphasizes how much more precarious the lifecycle is for cardiovascular medications.
  • "Research in this report beckons a deeper conversation on the IRA's potential implications for cardiovascular drug development and how that will shape the future of cardiovascular health care," Dharmesh Patel, MD, PACH president, said.